Aditxt subsidiary Ignite Proteomics to go public via $150M SPAC merger with Copley

Filed June 10, 2026 · Period ending June 10, 2026 · ~1 min read

Key Changes

• high

  Ignite Proteomics, Aditxt's wholly-owned subsidiary, signed definitive merger agreement with SPAC Copley Acquisition Corp valued at $150 million. Aditxt shareholders will receive 15 million shares in new public company Ignite Proteomics Holdings at $10/share.

  Item 1.01: Business Combination Agreement verify on EDGAR →
• high

  Deal requires $30M in new financing before closing: SPAC must raise up to $20M and Ignite up to $10M through equity, debt, or backstop arrangements. Minimum cash conditions require $15M from SPAC side and $7.5M from Ignite, or deal may fail.

  Item 1.01: Transaction Financing verify on EDGAR →
• high

  Aditxt guaranteed all of Ignite's obligations under merger agreement, including transaction expenses, debt repayment, and performance covenants. Parent company is financially liable if subsidiary fails to meet commitments.

  Item 1.01: Side Letter and Guaranty verify on EDGAR →